Associate Director & Head of Growth Projects at MRC Technology
Dr David Pardoe has an extensive 25 year background in discovering new therapeutics and research tools and has been instrumental in delivering four candidate molecules to the clinic. After leaving a management position at GlaxoSmithKline,
David spent seven years working as a consultant across the healthcare value chain delivering new diagnostics, devices and drugs that create real benefit for patients.
David is now Associate Director & Head of Growth Projects at MRC Technology in the UK. He works with medical research foundations, academia and industrial partners to accelerate and promote new medicines to patients through the development of novel operational and funding models.